Search results
Results from the WOW.Com Content Network
For the period ending Aug. 31, its sales grew by 13% year over year to $200 million. But of that total, less than one-third (31%) of sales actually came from its cannabis operations.
Is there a catalyst out there that can help Tilray's stock rebound in 2025? The last time Tilray's stock finished a year in positive territory was back in 2018, when its shares jumped by more than ...
Industry analysts forecast the market could reach $444 billion by 2030, representing a compound annual growth rate (CAGR) of 34.03% from 2023. ... Tilray has seen its stock price plummet a ...
In its fiscal first quarter of this year, ended Aug. 31, 28% of its total revenue, or $55.9 million, was from alcohol sales, whereas 31%, or $61.2 million, was from cannabis.
Tilray's stock continues moving in the wrong direction, and its share price is less than $2. Even at these levels, I'd recommend that investors stay away. Don’t miss this second chance at a ...
Once-promising Canadian cannabis cultivator Tilray (NASDAQ:TLRY) stock has lost its mojo in a big way. The company has swung from a profit to an earnings loss, according to Tilray’s most ...
In the budding cannabis industry, there will be winners and losers. And for one-time heavyweight contender Tilray (NASDAQ:TLRY), a mixed earnings report has delivered another blow. But don't think ...
Before trading kicks into action on Wednesday (April 6), Tilray (TLRY) will present F3Q22’s financial results (February quarter). Those with an optimistic bent might want to lower expectations ...